{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:50:04Z","timestamp":1754153404090,"version":"3.41.2"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1136\/ijgc-2018-000047","type":"journal-article","created":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T14:43:09Z","timestamp":1547476989000},"page":"365-376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Patterns of care and outcomes for women with uterine cancer and ovarian metastases"],"prefix":"10.1016","volume":"29","author":[{"given":"Nathaniel L","family":"Jones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongmei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudeshna","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana I","family":"Tergas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William M","family":"Burke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"June Y","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Israel","family":"Deutsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cande V","family":"Ananth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred I","family":"Neugut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawn L","family":"Hershman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason D","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2018-000047_bb0010","first-page":"7","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"issue":"Suppl 1","key":"10.1136\/ijgc-2018-000047_bb0015","first-page":"S105","article-title":"Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer","volume":"95","author":"Creasman","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1136\/ijgc-2018-000047_bb0020","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/AOG.0b013e3181f39849","article-title":"Comparative performance of the 2009 international Federation of gynecology and obstetrics' staging system for uterine corpus cancer","volume":"116","author":"Lewin","year":"2010","journal-title":"Obstet Gynecol"},{"year":"2017","author":"American Cancer Society","journal-title":"Cancer facts and figures","key":"10.1136\/ijgc-2018-000047_bb0025"},{"key":"10.1136\/ijgc-2018-000047_bb0030","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1002\/1097-0142(19930601)71:11<3697::AID-CNCR2820711137>3.0.CO;2-U","article-title":"Pathologic stage III endometrial carcinoma: prognostic factors and patterns of recurrence","volume":"71","author":"Greven","year":"1993","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2018-000047_bb0035","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0090-8258(87)90229-0","article-title":"Results of therapy, analysis of failures, and prognostic factors for clinical and pathologic stage III adenocarcinoma of the endometrium","volume":"27","author":"Grigsby","year":"1987","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2018-000047_bb0040","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/AOG.0b013e3181a94568","article-title":"Stage IIIA endometrial carcinoma: outcome and predictors of survival","volume":"114","author":"Bansal","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-2018-000047_bb0045","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ygyno.2005.03.033","article-title":"Practice patterns of SGO members for stage IIIA endometrial cancer","volume":"98","author":"Lee","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2018-000047_bb0050","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ygyno.2012.10.010","article-title":"A multicenter evaluation of adjuvant therapy in women with optimally resected stage IIIC endometrial cancer","volume":"128","author":"Secord","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2018-000047_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2016.06.1344","article-title":"Chemoradiation versus chemotherapy or radiation alone in stage iii endometrial cancer: patterns of care and impact on overall survival","volume":"96","author":"Boothe","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2018-000047_bb0060","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ygyno.2006.02.007","article-title":"Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin\/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer","volume":"103","author":"Greven","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2018-000047_bb0065","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1200\/JCO.2001.19.20.4048","article-title":"Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: a phase II study","volume":"19","author":"Hoskins","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2018-000047_bb0070","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ygyno.2007.09.025","article-title":"Pilot phase II trial of radiation \"sandwiched\" between combination paclitaxel\/platinum chemotherapy in patients with uterine papillary serous carcinoma (UPSC)","volume":"108","author":"Fields","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2018-000047_bb0075","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ygyno.2013.06.024","article-title":"Postoperative external beam radiation therapy and concurrent cisplatin followed by carboplatin\/paclitaxel for stage III (FIGO 2009) endometrial cancer","volume":"130","author":"Milgrom","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2018-000047_bb0080","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ygyno.2009.04.030","article-title":"Multicenter analysis of recurrence and survival in stage IIIA endometrial cancer","volume":"114","author":"Havrilesky","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2018-000047_bb0085","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1245\/s10434-007-9747-3","article-title":"The National Cancer Data Base: a powerful initiative to improve cancer care in the United States","volume":"15","author":"Bilimoria","year":"2008","journal-title":"Ann Surg Oncol"},{"unstructured":"American College of Surgeons . The National Cancer Data Base. American College of Surgeons.","key":"10.1136\/ijgc-2018-000047_bb0090"},{"key":"10.1136\/ijgc-2018-000047_bb0095","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1136\/ijgc-2018-000047_bb0100","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"10.1136\/ijgc-2018-000047_bb0105","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1001\/jama.2010.885","article-title":"Survival differences following lung transplantation among US transplant centers","volume":"304","author":"Thabut","year":"2010","journal-title":"JAMA"},{"key":"10.1136\/ijgc-2018-000047_bb0110","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","article-title":"Proportional hazards tests and diagnostics based on weighted residuals","volume":"81","author":"Grambsch","year":"1994","journal-title":"Biometrika"},{"key":"10.1136\/ijgc-2018-000047_bb0115","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.clon.2004.03.009","article-title":"Treatment results of endometrial carcinoma with positive peritoneal washing, adnexal involvement and serosal involvement","volume":"16","author":"Wong","year":"2004","journal-title":"Clin Oncol"},{"key":"10.1136\/ijgc-2018-000047_bb0120","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/962518","article-title":"Outcome of endometrial cancer Stage IIIA with Adnexa or serosal involvement Only","volume":"2011","author":"Jobsen","year":"2011","journal-title":"Obstet Gynecol Int"},{"key":"10.1136\/ijgc-2018-000047_bb0125","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0090-8258(80)90003-7","article-title":"Stage III adenocarcinoma of the endometrium: two prognostic groups","volume":"9","author":"Bruckman","year":"1980","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2018-000047_bb0130","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/gyno.1996.0274","article-title":"The effect of postsurgical therapy on stage III endometrial carcinoma","volume":"63","author":"Schorge","year":"1996","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2018-000047_bb0135","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1002\/1097-0142(197610)38:4<1838::AID-CNCR2820380462>3.0.CO;2-8","article-title":"The management of stage III carcinoma of the endometrium","volume":"38","author":"Antoniades","year":"1976","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2018-000047_bb0140","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ygyno.2009.06.035","article-title":"Node-positive adenocarcinoma of the endometrium: outcome and patterns of recurrence with and without external beam irradiation","volume":"115","author":"Klopp","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2018-000047_bb0145","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/0360-3016(91)90744-O","article-title":"Adjuvant whole abdominopelvic irradiation for high risk endometrial carcinoma","volume":"21","author":"Gibbons","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2018-000047_bb0150","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"key":"10.1136\/ijgc-2018-000047_bb0155","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1200\/JCO.2004.00.7617","article-title":"Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study","volume":"24","author":"Randall","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2018-000047_bb0160","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ygyno.2007.09.029","article-title":"Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study","volume":"108","author":"Susumu","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2018-000047_bb0165","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/sj.bjc.6603279","article-title":"Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial","volume":"95","author":"Maggi","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1136\/ijgc-2018-000047_bb0170","first-page":"Cd010681","article-title":"Adjuvant chemotherapy for advanced endometrial cancer","volume":"5","author":"Galaal","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1136\/ijgc-2018-000047_bb0175","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ygyno.2008.11.014","article-title":"A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: a gynecologic oncology group study","volume":"112","author":"Homesley","year":"2009","journal-title":"Gynecol Oncol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24010818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24010818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2018-000047","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:24:24Z","timestamp":1753233864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24010818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S1048891X24010818"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2018-000047","relation":{},"ISSN":["1048-891X"],"issn-type":[{"type":"print","value":"1048-891X"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patterns of care and outcomes for women with uterine cancer and ovarian metastases","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2018-000047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 IGCS and ESGO 2019. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}